Treatment of juvenile chronic myelocytic leukemia with multidrug chemotherapy including aclacinomycin and N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Ishii
E
E
Matsuzaki
A
A
Kato
Y
Y
Miyazaki
S
S
Ueda
K
K
D015250:Aclarubicin / Q000031:analogs & derivatives*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002675:Child, Preschool; D003561:Cytarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D009279:Naphthacenes / Q000627:therapeutic use
D009279:Naphthacenes; C011157:aclacinomycins; D003561:Cytarabine; D015250:Aclarubicin; C015019:enocitabine